At 32, CareLineLive's founder and Managing Director, Josh Hough features in this list of young entrepreneurs.

We’re dedicated to supporting carers and giving them more time to care—and the world is taking notice. Explore the stories that showcase our journey and the impact we’re making












Other Mentions, Press Coverage
At 32, CareLineLive's founder and Managing Director, Josh Hough features in this list of young entrepreneurs.

In Mental Health Awareness Week, Sales representative Jess Davies, at CareLineLive has revealed how her neurodiversity, the right to work from home...

The founder of a West Sussex tech company has told Insider how growing up with a rare muscle weakening illness fuelled his determination to...

A Sussex man who grew up in a wheelchair because of a rare muscle weakening illness is now running a multi-million-pound healthcare business.

As another new year beckons, a reflection on the home care sector reveals a year with both highs and lows. The continued work from carers and...

Technology moves at great speed and new regulation often follows – which is why it is essential for businesses to keep their fingers on the pulse of...

AI can transform healthcare by driving data, allowing providers to have quicker time to insights & deliver more personalised care says Andy Nieto,...

The healthcare industry, like many others, was impacted by the pandemic in 2020. The sector saw increased digitisation, less in-person interactions...

“While some of our development pathway is dictated by compliance and the needs of major partners like the NHS, I think it is also really important...

Meet Josh Hough, the Managing Director of CareLineLive, in this inspiring video where he shares the journey of creating a platform that’s...

Entrepreneurs often talk about having ‘skin in the game’ – meaning they have invested personally in their business – as a way of highlighting how...

Born with a rare muscle-weakening illness, Josh Hough was written off by doctors at an early age and grew up in a wheelchair.